共查询到20条相似文献,搜索用时 31 毫秒
1.
2.
Maria Mota Simona Georgiana Popa Eugen Mota Adina Mitrea Doina Catrinoiu Dan Mircea Cheta Cristian Guja Nicolae Hancu Constantin Ionescu‐Tirgoviste Radu Lichiardopol Bogdan Mircea Mihai Amorin Remus Popa Cornelia Zetu Cornelia Gabriela Bala Gabriela Roman Cristian Serafinceanu Viorel Serban Romulus Timar Ioan Andrei Veresiu Adrian Radu Vlad 《Journal of Diabetes》2016,8(3):336-344
3.
4.
Anoop Misra Hema Gopalan Ranil Jayawardena Andrew P. Hills Mario Soares Alfredo A. Reza‐Albarrán Kaushik L. Ramaiya 《Journal of Diabetes》2019,11(7):522-539
There has been a rapid escalation of type 2 diabetes (T2D) in developing countries, with varied prevalence according to rural vs urban habitat and degree of urbanization. Some ethnic groups (eg, South Asians, other Asians, and Africans), develop diabetes a decade earlier and at a lower body mass index than Whites, have prominent abdominal obesity, and accelerated the conversion from prediabetes to diabetes. The burden of complications, both macro‐ and microvascular, is substantial, but also varies according to populations. The syndemics of diabetes with HIV or tuberculosis are prevalent in many developing countries and predispose to each other. Screening for diabetes in large populations living in diverse habitats may not be cost‐effective, but targeted high‐risk screening may have a place. The cost of diagnostic tests and scarcity of health manpower pose substantial hurdles in the diagnosis and monitoring of patients. Efforts for prevention remain rudimentary in most developing countries. The quality of care is largely poor; hence, a substantial number of patients do not achieve treatment goals. This is further amplified by a delay in seeking treatment, “fatalistic attitudes”, high cost and non‐availability of drugs and insulins. To counter these numerous challenges, a renewed political commitment and mandate for health promotion and disease prevention are urgently needed. Several low‐cost innovative approaches have been trialed with encouraging outcomes, including training and deployment of non‐medical allied health professionals and the use of mobile phones and telemedicine to deliver simple health messages for the prevention and management of T2D. 相似文献
5.
6.
Efficacy and safety of pregabalin for painful diabetic peripheral neuropathy in a population of Chinese patients: A randomized placebo‐controlled trial 下载免费PDF全文
Yiming Mu Xiaomin Liu Quanmin Li Kangning Chen Yu Liu Xiaofeng Lv Xiangjin Xu Dongsheng Fan Ningxiu Shang Ruoyong Yang Lynne Pauer Changyu Pan 《Journal of Diabetes》2018,10(3):256-265
7.
Demographic and clinical characteristics of patients with type 1 diabetes mellitus: A multicenter registry study in Guangdong,China 下载免费PDF全文
Daizhi Yang Hongrong Deng Guochun Luo Ge Wu Shaoda Lin Lin Yuan Meilun Xv Shaoqing Li Xiuwei Zhang Jianneng Wu Jiangming Lang Ganxiong Liang Jiancai Lin Dingyu Chen Lu Li Yishan Fang Yongxin Wu Wenxin Ou Jin Li Jianping Weng Jinhua Yan 《Journal of Diabetes》2016,8(6):847-853
8.
9.
10.
11.
12.
13.
14.
Heparan sulfate inhibits inflammation and improves wound healing by downregulating the NLR family pyrin domain containing 3 (NLRP3) inflammasome in diabetic rats 下载免费PDF全文
Tao Wang Jun Zhao Jian Zhang Jiacai Mei Mingzhe Shao Ye Pan Wenchao Yang Yujie Jiang Fang Liu Weiping Jia 《Journal of Diabetes》2018,10(7):556-563
15.
16.
17.
Association between smoking and glycemic control in diabetic patients: Results from the Risk Evaluation of cAncers in Chinese diabeTic Individuals: A lONgitudinal (REACTION) study 下载免费PDF全文
Kui Peng Gang Chen Chao Liu Yiming Mu Zhen Ye Lixin Shi Jiajun Zhao Lulu Chen Qiang Li Tao Yang Li Yan Qin Wan Shengli Wu Guixia Wang Zuojie Luo Xulei Tang Yanan Huo Zhengnan Gao Qing Su Youmin Wang Guijun Qin Huacong Deng Xuefeng Yu Feixia Shen Li Chen Liebin Zhao Yu Xu Min Xu Yuhong Chen Jieli Lu Lin Lin Rui Du Meng Dai Mian Li Tiange Wang Zhiyun Zhao Di Zhang Yufang Bi Donghui Li Weiqing Wang Guang Ning 《Journal of Diabetes》2018,10(5):408-418
18.
19.
Fish are good for your health in more ways than you may expect. For one, eating fish is a common dietary recommendation for a healthy diet. However, fish have much more to provide than omega‐3 fatty acids to your circulatory system. Some fish species now serve as important and innovative model systems for diabetes research, providing novel and unique advantages compared with classical research models. Not surprisingly, the largest share of diabetes research in fish occurs in the laboratory workhorse among fish, the zebrafish (Danio rerio). Established as a genetic model system to study development, these small cyprinid fish have eventually conquered almost every scientific discipline and, over the past decade, have emerged as an important model system for metabolic diseases, including diabetes mellitus. In this review we highlight the practicability of using zebrafish to study diabetes and hyperglycemia, and summarize some of the recent research and breakthroughs made using this model. Equally exciting is the appearance of another emerging discipline, one that is taking advantage of evolution by studying cases of naturally occurring insulin resistance in fish species. We briefly discuss two such models in this review, namely the rainbow trout (Oncorhynchus mykiss) and the cavefish (Astyanax mexicanus). 相似文献